Page 146 - Case Lab Case Analysis
P. 146

BACKGROUND





               MYLAN


               One of world’s leading generics and pharmaceutical

               companies


                       •Global
                       •165 countries

                       •1,400 current products

                       •EpiPen is top-seller (2015)
                       •More than $1 billion / $9.5

                       •3.6 million prescriptions (IMS Health)

                       •
   141   142   143   144   145   146   147   148   149   150   151